Whitehawk Therapeutics Inc
USD3.91
+0.12 (+3.17%)
CEO
David J. Lennon
IPO Date
2017-08-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.80
Prev. Close
$3.79
Day Low
$3.77
Day High
$3.97
52W Low
$1.57
52W High
$5.50
Market Cap
$0.19B
Volume
0.29M
| 38,040 |
| $4.16 |
| 15 Jun 2026 | Maroun Richard E | director | A-Award | Acquired | 38,040 | $4.16 |
| 15 Jun 2026 | Hirmand Mohammad | director | A-Award | Acquired | 38,040 | $4.16 |
| 15 Jun 2026 | Desai Neil | director | A-Award | Acquired | 38,040 | $4.16 |
| 15 Jun 2026 | Castelein Caley | director | A-Award | Acquired | 38,040 | $4.16 |
| 15 Jun 2026 | Aghazadeh Behzad | director, 10 percent owner, other: See remarks | A-Award | Acquired | 38,040 | $4.16 |
| 18 May 2026 | Dugan Margaret | Chief Medical Officer | A-Award | Acquired | 19,132 | $3.92 |
| 18 May 2026 | BALL BRYAN | See remarks | A-Award | Acquired | 51,020 | $3.92 |
| 18 May 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A-Award | Acquired | 38,265 | $3.92 |